April 2024
1. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
   Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
   BMJ. 2024;385:e076268.
   

   >> Share

   
   
2. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
   Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
   BMJ. 2024;385:e077209.
   

   >> Share

   
   March 2024
3. KAVIRAJ C
   Caring is the invisible piece of the stroke recovery puzzle.
   BMJ. 2024;384:q286.
   

   >> Share

   
   
4. CROCKER TF, Ensor J, Lam N, Jordao M, et al
   Community based complex interventions to sustain independence in older people: systematic review and network meta-analysis.
   BMJ. 2024;384:e077764.
   

   >> Share

   
   
5. NOLAN T
   The impact of response times on effect of thrombolysis and other research.
   BMJ. 2024;384:q601.
   

   >> Share

   
   
6. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
   Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
   BMJ. 2024;384:q516.
   

   >> Share

   
   February 2024
7. KMIETOWICZ Z
   Sponge-on-a-string test replaces need for endoscopy in eight in 10 reflux patients.
   BMJ. 2024;384:q501.
   

   >> Share

   
   
8. KIM KS, Hong S, Han K, Park CY, et al
   Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
   BMJ. 2024;384:e076388.
   

   >> Share

   
   
9. MAHASE E
   Variability in blood pressure could help predict heart attack and stroke risk, researchers say.
   BMJ. 2024;384:q363.
   

   >> Share

   
   January 2024
10. 
    Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    BMJ. 2024;384:q131.
    

    >> Share

    
    November 2023
11. LELIEVELD J, Haines A, Burnett R, Tonne C, et al
    Air pollution deaths attributable to fossil fuels: observational and modelling study.
    BMJ. 2023;383:e077784.
    

    >> Share

    
    
12. KHAN SU, Agarwal S, Arshad HB, Akbar UA, et al
    Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis.
    BMJ. 2023;383:e077848.
    

    >> Share

    
    
13. SAUL H, Cassidy S, Deeney B, Imison C, et al
    Early, intense therapy for language problems after a stroke is linked to the greatest benefits.
    BMJ. 2023;383:p2560.
    

    >> Share

    
    October 2023
14. ILIEVA H, Vullaganti M, Kwan J
    Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.
    BMJ. 2023;383:e075037.
    

    >> Share

    
    
15. LEE YJ, Hong SJ, Kang WC, Hong BK, et al
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ. 2023;383:e075837.
    

    >> Share

    
    
16. MAHASE E
    Stroke patients should be offered at least 15 hours of rehabilitation a week, NICE advises.
    BMJ. 2023;383:p2417.
    

    >> Share

    
    
17. OXTOBY K
    Calm under pressure: the stroke physician.
    BMJ. 2023;383:p2123.
    

    >> Share

    
    
18. LIU L, Xie X, Pan Y, Wang A, et al
    Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial.
    BMJ. 2023;383:e076448.
    

    >> Share

    
    
19. RIMMER A
    GP's mistakes led to patient losing sight after a stroke, says ombudsman.
    BMJ. 2023;383:p2306.
    

    >> Share

    
    September 2023
20. HOLMBERG D, Santoni G, von Euler-Chelpin M, Farkkila M, et al
    Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study.
    BMJ. 2023;382:e076017.
    

    >> Share

    
    August 2023
21. BROWN RL, Benjamin L, Lunn MP, Bharucha T, et al
    Pathophysiology, diagnosis, and management of neuroinflammation in covid-19.
    BMJ. 2023;382:e073923.
    

    >> Share

    
    June 2023
22. THOMPSON B, Waterhouse M, English DR, McLeod DS, et al
    Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial.
    BMJ. 2023;381:e075230.
    

    >> Share

    
    
23. GALE CP, Stocken DD, Aktaa S, Reynolds C, et al
    Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial.
    BMJ. 2023;381:e073843.
    

    >> Share

    
    May 2023
24. KMIETOWICZ Z
    Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICE.
    BMJ. 2023;381:p1146.
    

    >> Share

    
    April 2023
25. SHI Q, Nong K, Vandvik PO, Guyatt GH, et al
    Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2023;381:e074068.
    

    >> Share

    
    March 2023
26. KARAM G, Agarwal A, Sadeghirad B, Jalink M, et al
    Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis.
    BMJ. 2023;380:e072003.
    

    >> Share

    
    
27. MORALES DR, Minchin M, Kontopantelis E, Roland M, et al
    Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis.
    BMJ. 2023;380:e072098.
    

    >> Share

    
    February 2023
28. MAO YP, Wang SX, Gao TS, Zhang N, et al
    Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
    BMJ. 2023;380:e072133.
    

    >> Share

    
    January 2023
29. SKAJAA N, Adelborg K, Horvath-Puho E, Rothman KJ, et al
    Labour market participation and retirement after stroke in Denmark: registry based cohort study.
    BMJ. 2023;380:e072308.
    

    >> Share

    
    December 2022
30. DAY J, Lashley D
    An unusual cause of stroke.
    BMJ. 2022;379:e066326.
    

    >> Share

    
    November 2022
31. DIGUISTO C, Saucedo M, Kallianidis A, Bloemenkamp K, et al
    Maternal mortality in eight European countries with enhanced surveillance systems: descriptive population based study.
    BMJ. 2022;379:e070621.
    

    >> Share

    
    October 2022
32. 
    Comparative effectiveness of initial computed tomography and invasive coronary angiography in women and men with stable chest pain and suspected coronary artery disease: multicentre randomised trial.
    BMJ. 2022;379:e071133.
    

    >> Share

    
    
33. MAHASE E
    Atrial fibrillation: Most UK media "promote screening" despite lack of evidence, study finds.
    BMJ. 2022;379:o2449.
    

    >> Share

    
    September 2022
34. XIE W, Wang Y, Xiao S, Qiu L, et al
    Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    BMJ. 2022;378:e070244.
    

    >> Share

    
    June 2022
35. LIANG C, Chung HF, Dobson AJ, Hayashi K, et al
    Infertility, recurrent pregnancy loss, and risk of stroke: pooled analysis of individual patient data of 618 851 women.
    BMJ. 2022;377:e070603.
    

    >> Share

    
    
36. WISE J
    NICE endorses new drug to prevent myocardial infarctions and strokes.
    BMJ. 2022;377:o1444.
    

    >> Share

    
    
37. WISE J
    Atrial fibrillation study shows inequalities in care.
    BMJ. 2022;377:o1403.
    

    >> Share

    
    May 2022
38. KHAN SU, Yedlapati SH, Lone AN, Hao Q, et al
    PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    BMJ. 2022;377:e069116.
    

    >> Share

    
    
39. HAO Q, Aertgeerts B, Guyatt G, Bekkering GE, et al
    PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    BMJ. 2022;377:e069066.
    

    >> Share

    
    April 2022
40. JUURLINK DN
    Antiemetics, stroke, and the limits of observational epidemiology.
    BMJ. 2022;377:o924.
    

    >> Share

    
    March 2022
41. BENARD-LARIBIERE A, Hucteau E, Debette S, Kirchgesner J, et al
    Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study.
    BMJ. 2022;376:e066192.
    

    >> Share

    
    February 2022
42. MAC GRORY B, Ohman EM, Feng W, Xian Y, et al
    Advances in the management of cardioembolic stroke associated with patent foramen ovale.
    BMJ. 2022;376:e063161.
    

    >> Share

    
    January 2022
43. WATT JA, Del Giovane C, Jackson D, Turner RM, et al
    Incorporating dose effects in network meta-analysis.
    BMJ. 2022;376:e067003.
    

    >> Share

    
    August 2021
44. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    

    >> Share

    
    June 2021
45. BURNS TC, Quinones-Hinojosa A
    Regenerative medicine for neurological diseases-will regenerative neurosurgery deliver?
    BMJ. 2021;373:n955.
    

    >> Share

    
    
46. VALGIMIGLI M, Gragnano F, Branca M, Franzone A, et al
    P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
    BMJ. 2021;373:n1332.
    

    >> Share

    
    
47. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ. 2021;373:n1205.
    

    >> Share

    
    May 2021
48. PERRY M, Kemmis Betty S, Downes N, Andrews N, et al
    Atrial fibrillation: diagnosis and management-summary of NICE guidance.
    BMJ. 2021;373:n1150.
    

    >> Share

    
    
49. KIM D, Yang PS, You SC, Sung JH, et al
    Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2021;373:n991.
    

    >> Share

    
    April 2021
50. PONAMGI SP, Siontis KC, Rushlow DR, Graff-Radford J, et al
    Screening and management of atrial fibrillation in primary care.
    BMJ. 2021;373:n379.
    

    >> Share

    
    
51. WOOD A, Denholm R, Hollings S, Cooper J, et al
    Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
    BMJ. 2021;373:n826.
    

    >> Share

    
    February 2021
52. 
    Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.
    BMJ. 2021;372:n453.
    

    >> Share

    
    
53. PERRY JJ, Sivilotti MLA, Emond M, Stiell IG, et al
    Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.
    BMJ. 2021;372:n49.
    

    >> Share

    
    October 2020
54. WANG DZ, Schwamm LH, Qian T, Dai Q, et al
    Decoding the brain through research-the future of brain health.
    BMJ. 2020;371:m3735.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share